BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 20527538)

  • 1. Experimental and theoretical dosimetry of a new polymer encapsulated iodine-125 source--SmartSeed: dosimetric impact of fluorescence x rays.
    Abboud F; Hollows M; Scalliet P; Vynckier S
    Med Phys; 2010 May; 37(5):2054-62. PubMed ID: 20527538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An experimental palladium-103 seed (OptiSeedexp) in a biocompatible polymer without a gold marker: characterization of dosimetric parameters including the interseed effect.
    Abboud F; Scalliet P; Vynckier S
    Med Phys; 2008 Dec; 35(12):5841-50. PubMed ID: 19175140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source.
    Sheikholeslami S; Nedaie HA; Sadeghi M; Pourbeigy H; Shahzadi S; Zehtabian M; Hasani M; Meigooni AS
    J Appl Clin Med Phys; 2016 Jul; 17(4):430-441. PubMed ID: 27455485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermoluminescent dosimetry of the Symmetra 125I model I25.S06 interstitial brachytherapy seed.
    Patel NS; Chiu-Tsao ST; Williamson JF; Fan P; Duckworth T; Shasha D; Harrison LB
    Med Phys; 2001 Aug; 28(8):1761-9. PubMed ID: 11548947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric characteristics of the Pharma Seed model BT-125-I source.
    Popescu CC; Wise J; Sowards K; Meigooni AS; Ibbott GS
    Med Phys; 2000 Sep; 27(9):2174-81. PubMed ID: 11011748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
    Aryal P; Molloy JA; Rivard MJ
    Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymer gel dosimetry for the TG-43 dosimetric characterization of a new 125I interstitial brachytherapy seed.
    Papagiannis P; Pantelis E; Georgiou E; Karaiskos P; Angelopoulos A; Sakelliou L; Stiliaris S; Baltas D; Seimenis I
    Phys Med Biol; 2006 Apr; 51(8):2101-11. PubMed ID: 16585848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental determination of the Task Group-43 dosimetric parameters of the new I25.S17plus (125)I brachytherapy source.
    Moutsatsos A; Pantelis E; Papagiannis P; Baltas D
    Brachytherapy; 2014; 13(6):618-26. PubMed ID: 25108795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monte Carlo and thermoluminescence dosimetry of the new IsoSeed model I25.S17 125I interstitial brachytherapy seed.
    Lymperopoulou G; Papagiannis P; Sakelliou L; Karaiskos P; Sandilos P; Przykutta A; Baltas D
    Med Phys; 2005 Nov; 32(11):3313-7. PubMed ID: 16370418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the dosimetric parameters of
    Ait-Mlouk L; Khalis M; Asnaoui H; Ouabi H; Elboukhari S
    Appl Radiat Isot; 2022 Aug; 186():110294. PubMed ID: 35660985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monte Carlo calculations of AAPM Task Group Report No. 43 dosimetry parameters for the (125)I I-Seed AgX100 source model.
    Mourtada F; Mikell J; Ibbott G
    Brachytherapy; 2012; 11(3):237-44. PubMed ID: 21816684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
    Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
    Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric characteristics of the InterSource103 palladium brachytherapy source.
    Meigooni AS; Sowards K; Soldano M
    Med Phys; 2000 May; 27(5):1093-100. PubMed ID: 10841414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
    Ho Than MT; Munro Iii JJ; Medich DC
    J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monte Carlo calculated TG-43 dosimetry parameters for the SeedLink 125Iodine brachytherapy system.
    Medich DC; Munro JJ
    Med Phys; 2003 Sep; 30(9):2503-8. PubMed ID: 14528972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of new GAFCHROMIC EBT film for 125I seed dosimetry in Solid Water phantom.
    Chiu-Tsao ST; Medich D; Munro J
    Med Phys; 2008 Aug; 35(8):3787-99. PubMed ID: 18777938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monte Carlo-aided dosimetry of the new Bebig IsoSeed 103Pd interstitial brachytherapy seed.
    Daskalov GM; Williamson JF
    Med Phys; 2001 Oct; 28(10):2154-61. PubMed ID: 11695778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monte Carlo and experimental dosimetry of an 1251 brachytherapy seed.
    Dolan J; Lia Z; Williamson JF
    Med Phys; 2006 Dec; 33(12):4675-84. PubMed ID: 17278820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric study of a new polymer encapsulated palladium-103 seed.
    Bernard S; Vynckier S
    Phys Med Biol; 2005 Apr; 50(7):1493-504. PubMed ID: 15798339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric characteristics of a new 125I brachytherapy source.
    Gearheart DM; Drogin A; Sowards K; Meigooni AS; Ibbott GS
    Med Phys; 2000 Oct; 27(10):2278-85. PubMed ID: 11099194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.